---
schema_version: "secwatch.filing_event.v1"
accession: "0001568651-23-000006"
form_type: "8-K"
ticker: "OSCR"
cik: "0001568651"
company_name: "Oscar Health, Inc."
filed_at: "2023-02-09T23:59:59+00:00"
generated_at: "2026-06-19T20:17:07.980069+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Oscar Health reports FY 2022 net loss $610M; guides 2023 to near breakeven adjusted EBITDA

## Summary
- Full-year 2022 premiums earned $3.9B, up 111% YoY; Direct & Assumed Policy Premiums $6.8B, up 99%.
- Membership reached 1,151,483 as of Dec 31, 2022, a 93% increase YoY, led by Individual & Small Group.
- Medical Loss Ratio improved 360 bps to 85.3%; InsuranceCo Combined Ratio improved 490 bps to 105.8%.
- 2023 outlook: Direct & Assumed Policy Premiums $6.4B-$6.6B, InsuranceCo Combined Ratio ≤100%.
- Guides FY 2023 Adjusted EBITDA loss of ($175M)-($75M), significantly improved from ($462M) in 2022.

## SEC filing metadata
- accession: 0001568651-23-000006
- form_type: 8-K
- ticker: OSCR
- cik: 0001568651
- company_name: Oscar Health, Inc.
- filed_at: 2023-02-09T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1568651/000156865123000006/0001568651-23-000006-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1568651/000156865123000006/oscr-20230209.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001568651-23-000006
- JSON: https://secwatch.observer/filing/0001568651-23-000006.json
- Plain text: https://secwatch.observer/filing/0001568651-23-000006.txt

## Key facts
- Earnings Releases
  Oscar Health, Inc. reported the fourth quarter and year ended December 31, 2022 results: net income Net loss of $610 million. Guidance reaffirmed.
  - Period: the fourth quarter and year ended December 31, 2022
  - Net income: Net loss of $610 million
  - Guidance: reaffirmed
  - Result: reported results
  source text: On February 9, 2023, Oscar Health, Inc. (the “Company”) announced the Company’s financial results for the fourth quarter and year ended December 31, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1568651/000156865123000006/0001568651-23-000006-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.